BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25841947)

  • 1. Treatment of bladder transitional cell carcinoma in children: a single center experience from China.
    Huang H; Li X; Jin J
    Arch Iran Med; 2015 Apr; 18(4):250-2. PubMed ID: 25841947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitional-cell carcinoma of the bladder in an adolescent.
    Tsuchiya H; Nagashima K; Takahashi T
    Pediatr Surg Int; 1999; 15(8):588-90. PubMed ID: 10631744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urothelial neoplasm of the bladder in childhood and adolescence: a rare disease.
    Polat H; Utangac MM; Gulpinar MT; Cift A; Erdogdu IH; Turkcu G
    Int Braz J Urol; 2016; 42(2):242-6. PubMed ID: 27256177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recurrent transitional cell carcinoma of the bladder in a young woman: report of a case].
    Ikeda I; Terao T; Nakagomi K; Masuda M; Hirokawa M
    Hinyokika Kiyo; 1992 Nov; 38(11):1261-3. PubMed ID: 1485578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urothelial carcinoma of the urinary bladder in pediatric patients: a long-term follow-up.
    Ander H; Dönmez Mİ; Yitgin Y; Tefik T; Ziylan O; Oktar T; Özsoy M
    Int Urol Nephrol; 2015 May; 47(5):771-4. PubMed ID: 25787072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
    Hendricksen K; Gleason D; Young JM; Saltzstein D; Gershman A; Lerner S; Witjes JA
    J Urol; 2008 Jul; 180(1):116-20. PubMed ID: 18485407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of transitional cell carcinoma of the bladder in childhood.
    Bujons A; Caffaratti J; Garat JM; Villavicencio H
    J Pediatr Urol; 2014 Feb; 10(1):167-70. PubMed ID: 24035638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent malakoplakia and papillary urothelial carcinoma of the urinary bladder.
    Darvishian F; Teichberg S; Meyersfield S; Urmacher CD
    Ann Clin Lab Sci; 2001 Apr; 31(2):147-50. PubMed ID: 11337903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Guérin.
    Angulo JC; Palou J; García-Tello A; de Fata FR; Rodríguez O; Villavicencio H
    Actas Urol Esp; 2014 Apr; 38(3):164-71. PubMed ID: 24613147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transurethral Resection of the Bladder Tumour as a Treatment Method in Children with Transitional Cell Carcinoma of the Bladder--Analysis of Our Material and Literature Review.
    Apoznański W; Rysiakiewicz J; Polok M; Rysiakiewicz K; Siekanowicz P; Hilger T; Zagierski J; Hilger M; Nowak I; Kolęda P; Szydełko T
    Adv Clin Exp Med; 2015; 24(3):505-9. PubMed ID: 26467141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern and risk factors of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a large Chinese center experience.
    Fang D; Xiong GY; Li XS; Chen XP; Zhang L; Yao L; He ZS; Zhou LQ
    J Formos Med Assoc; 2014 Nov; 113(11):820-7. PubMed ID: 24360737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade transitional cell carcinoma of the pediatric bladder.
    Korrect GS; Minevich EA; Sivan B
    J Pediatr Urol; 2012 Jun; 8(3):e36-8. PubMed ID: 22105002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological changes due to intravesical instillation of mitomycin C.
    Castillo OA; Landerer E; Feria-Flores M; Vidal-Mora I; Franco C
    Arch Esp Urol; 2012 Jun; 65(5):578-82; discussion 582. PubMed ID: 22732786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expectant management of small, recurrent, noninvasive papillary bladder tumors.
    Soloway MS; Bruck DS; Kim SS
    J Urol; 2003 Aug; 170(2 Pt 1):438-41. PubMed ID: 12853794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
    Skolarikos A; Chrisofos M; Ferakis N; Papatsoris A; Dellis A; Deliveliotis C
    J Urol; 2005 Jun; 173(6):1908-11. PubMed ID: 15879773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Squamous metaplasia as a prognostic factor in urothelial carcinoma of the bladder].
    Vecchioli Scaldazza C; Morosetti C
    Minerva Urol Nefrol; 1992; 44(2):97-100. PubMed ID: 1411869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent and up-grading bladder cancer in a young female: a case report].
    Ouchi H; Noguchi S; Masuda M; Yao M; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1996 Apr; 42(4):311-3. PubMed ID: 8693967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.